The pooled prevalence of long COVID during different follow-up durations The prevalence of any symptom exhibited a decreasing trend with the progress of follow-up ( Fig. 4 ), they were 26.41 % ([95 % CI 14.33–40.59], I 2 =100 %; N = 11), 20.6 4% ([95 % CI 17.06–24.46], I 2 =31 %; N = 5), and 14.89 % ([95 % CI 6.09–26.51], I 2 =75 %; N = 2) during 3–6, 6–12, and> 12 months, respectively.
← all excerpts
Prevalence and risk factor for long COVID in children and adolescents: A meta-analysis and systematic review.
1
—
—